-
US clears paediatric use of GSK’s Arnuity Ellipta
pharmatimes
May 24, 2018
US regulators have issued a green light for the once-daily inhaler as maintenance treatment of asthma in children from as young as five years.
-
Doctors in US and Canada launch sweeping pharmaceutical reform proposal
worldpharmanews
May 23, 2018
The skyrocketing cost of prescription drugs is one of the biggest concerns for American voters. However, in his proposal last Friday,
-
US FDA completes inspection of Lupin’s Nagpur plant
financialexpress
May 21, 2018
Lupin said the US health regulator has completed inspection of its Nagpur facility without making any observations.
-
Goran Pharma’s Gujarat facility receives US FDA warning for CGMP Violations
financialexpress
May 21, 2018
Goran Pharma’s Sihor facility in Gujarat has received a US FDA warning letter. Reportedly, deviations from current good manufacturing practices (CGMPs),
-
Jubilant Life gets US FDA nod for heart drug
financialexpress
May 21, 2018
Jubilant Life Sciences has received the final approval from US FDA for its generic Niacin extended-release tablets used for controlling cholesterol levels.
-
Granules gets US FDA nod for postpartum haemorrhage prevention drug
financialexpress
May 21, 2018
Granules India said its subsidiary has received approval from the US health regulator for Methylergonovine tablets, used for the prevention and control of postpartum haemorrhage.
-
Divis Labs Choutuppal Unit-1 gets US FDA nod
financialexpress
May 21, 2018
Divis Laboratories Choutuppal Unit 1 in Telangana was recently undergone an US FDA inspection.
-
Indoco facilities bag US FDA nod
financialexpress
May 21, 2018
Indoco Remedies announced the successful completion of US FDA inspection at its API manufacturing facilities at Patalganga and Rabale, Navi Mumbai.
-
A Glimpse of Influences of Tariff Slapping on the Chinese Pharmaceutical Industry at the Sensitive Time of Sino-U.S. Trade Friction
Xiaoyaowan
April 23, 2018
News about the trade war between the U.S. and China recently has been stirring the market nerves.
-
Amgen to build first-of-its-kind biomanufacturing plant in the US
cphi-online
April 11, 2018
Revolutionary, innovative plant offers greater flexibility, speed and efficiency.